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Abstract: Pregnant-origin Gram negative enteric bacteria, particularly, Escherichia coli isolates were 
exposed to tests for resistance phenotype using Kirby-Bauer’s disk-diffusion assay and for gentamicin 
resistance genotype using aacC2gene, codifying for one specific aminoglycoside-modifying enzyme. The 
incidence of Enterobacteriaceae was 31 (21.8%), emerged from142 midstream urine (MSU) samples, 
including symptomatic (17.6%) and asymptomatic (25.7%) bacteriuria. Women with age brackets from 
15-44 years were studied. Age group 25-29 years scored the highest incidence rate of infection (29.2%), 
while age group 35-39 years exhibited the lowest incidence rate. Data described previously were 
statistically insignificant (P value > 0.05). Remarkably, significant differences (P value <0.05) observed 
concerning gestational ages when third (32.81%) and second (14.81%) trimesters were noticed with the 
highest rate of bacteriuria, respectively. E. coli distinguished as the most predominant (41.9%), followed 
by Klebssiella pneumoniae (19.4%) and Pseudomonas aeruginosa (12.9%), consecutively. Seven other 
uropathogens were identified with a lesser frequency. Isolates subjected to numerous antibiotics and 
results revealed fully resistance to pencillin G and amoxicillin-clavulanic acid, while (96.8%) possessed 
resistant to amoxicillin, cephlexin, and vancomycin. However, amikacin still acting perfectly (90.3%) 
against all the isolates, especially towards E. coli (92.3%). Concurrently, the antimicrobial potency of 
streptomycin, ciprofloxacin, and ceftriaxone were (92.3%), (84.6%), and (77%) respectively, when 
assayed opposite E. coli strains solely. Phenotypically, (30.8%) of E. coli strains, which stand for about 
(32.3%) of the whole isolates, were resistance to gentamicin. 75% of phenotypically gentamicin 
resistance E. coli demonstrated genotypically as harbouring the aacC2 gene. 
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1. Introduction 
Urinary tract infections (UTI) considered as the second most common clinical problem (Thapa et al., 
2015). It is agreed from the past forty decades that UTI is more prevalent in pregnant women than in 
non-pregnant by about 4 – 10 times (Shulman & Herlinger, 1975). The physio-anatomical and 
functional perturbation that happen to the urinary system during pregnancy, in particular a decrease 
in the urine concentration by virtue of the physiological increase in plasma volume, equal to 70% of 
pregnant women evolve glucosuria, which facilitates bacterial growth in the urine (Murtaza, 2002; 
Lucas & Cunningham, 1993). 
 
Bacteriuria may exhibit as asymptomatic or symptomatic (Connolly & Thorp, 1999). Asymptomatic 
infections usually ascribed to pregnant women and the elderly (Al-Dujiaily, 2000). Various factors 
including low socioeconomic status, multiparty, age, sexual behaviour, urinary tract anomalies, and 
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previous treatment for UTI, in addition to diabetes, sickle cell anaemia, and immuno-compromised 
patients had been linked to asymptomatic bacteriuria (Murtaza, 2002; Njoku et al., 1998). Untreated 
UTI can be associated with serious obstetric complications. These consist of caesarean and preterm 
deliveries with low birth weight infants, intrauterine growth retardation, fatal death, preeclampsia, 
maternal sepsis and respiratory insufficiency (Shulman & Herlinger, 1975; Moyo et al., 2010; 
Mohamed, 2012).  
 
Among diverse pathogens that cause UTIs during pregnancy, E. coli with its multidrug resistant 
strains considered as predominant (Dalzell & Lefevre, 2000; Kariuki et al., 2007). Klebsiella, 
Enterobacter, and Proteus species, in addition to gram positive isolates, such as Staphylococcus 
saprophyticus and Enterococcus account for the remaining cases (Gilstrap & Ramin, 2001; Masinde 
et al., 2009). It is strongly recommended that screening and treatment of asymptomatic bacteriuria in 
pregnant women should be performed on time to minimize the unfavourable consequences (Nicolle, 
2006). Unfortunately, urinary tract pathogens evolved resistance to antibiotics, and it has been 
known to increase over the time (Kahlmeter, 2003). Moreover, the manner by which these 
pathogenic strains gain resistance to the antibiotics varied depending on the position of isolation and 
the geographical area (Jamie et al., 2002). In 2009, resistance of infectious agents to highly potent 
aminoglycosides was of special concern, since they are used widely for the management of various 
infections. Diverse mechanisms formulated to explain the resistance that can cohabit in the same 
cell; they are mediated by the enzymatic modification via acetyltransferases, nucleotidyltransferases, 
and phosphotransferases (Dias-Goncalves et al., 2015; Davis et al., 2010). Genetically, in most of the 
instances, the aacC2 (gentamicin-resistance) gene identified most frequently in strains of gram-
negative Enterobacteriaceae separated from clinical specimens (Lindemann et al., 2011). 
Additionally, it has been detected that these genes are often located on transposons, which plays an 
important role in the dissemination of drug resistance across inter and intra species boundaries 
(Ramirez & Tolmasky, 2010). Interestingly, intrinsic resistance of Streptomyces and 
Micromonospora species, the aminoglycoside-producing bacteria to aminoglycosides explained by 
the methylation of nucleotides situated within the A site of the 16S rRNA, thus preventing the 
disruption of translation process by aminoglycosides (Davis et al., 2010). 
 
Due to impractical and incredible prescription of gentamicin by Gynecologist and Obstetrics to 
women suffered from UTI before or even during pregnancy in some area of Asia, in particular Iraq, 
we found it of great issue to undertake this study. We aimed to determine the incidence of Gram 
negative bacteriuria in a population of pregnant women with investigating various attributed 
pathogenic microbes, in addition to checking for the antibiotic susceptibility while focusing on 
gentamicin resistant E. coli to allocate it with the molecular pattern that confer gentamicin resistance. 
 
2. Materials and Methods  
2.1 Study Population 
A study was conducted from November 2015 to February 2016 at both Sheray Naqeeb Maternity 
Hospital and Sherwana Health Centre, Kalar, Kurdistan region, Iraq. Pregnant women regardless of 
symptoms of UTI between the ages of 15 to 43 years with no gestational age limits were included, 
while those who received antibiotics therapy within at least 72 hours and non-pregnant women were 
excluded in this study. Information about age, duration of gestation and symptoms of UTI was 
obtained from each pregnant woman using standard questionnaires and kept confidential during the 
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2.2 Sample Collection and Bacterial Identification 
Total of 142 mid-stream urine (MSU) samples were collected aseptically in sterile disposable 
containers. Specimens labelled and transported to the microbiology laboratory. A calibrated sterile 
platinum wire loop was used to transfer 1μl of uncentrifuged urine specimen and streaked on 
MacConkey agar. All inoculated plates were incubated at 37°C for 18-24 hours. Significant 
bacteriuria in both symptomatic and asymptomatic pregnant women was defined by ≥ 105 colony 
forming units (CFU) per mL of urine (Stamm et al., 1982). Whole isolates were identified using 
classical biochemical methods (Cheesebrough, 2004; Prescott et al., 2008), while investigation of E. 
coli strains carried out biochemically and by molecular techniques (PCR) using primers designed for 
16S rRNA (Table, 1). 
2.3 Antibiotic Susceptibility Testing  
 
Antimicrobial susceptibility test (AST) was performed for all the isolates by Kirby-Bauer’s disk-
diffusion method (Bauer et al., 1966) as recommended by Clinical and Laboratory Standard Institute 
(CLSI, 2012). Disks of 16 different antibiotics (Bioanalyse, Turkey) including vancomycin (10μg), 
amikacin (30μg), amoxicillin (25μg), amoxicillin/clavulanic acid (30μg) gentamicin (10μg), rifampin 
(5μg), azithromycin (15μg), cephalexin (30μg), trimethoprim (10μg), nalidixic acid (30μg), 
nitrofurantoin (100μg), tetracycline (10μg), and penicillin G (10μg) were spread on fresh plates of 
Mueller-Hinton agar and incubated overnight at 37°C. E. coli ATCC25922 was used as a reference 
strain for the identification and AST. 
 
2.4 DNA Extraction 
 
Genomic DNA was extracted from clinical isolates of E. coli using boil preparation method (a single 
colony from each isolates was carefully suspended in 50μl of deionized water, then boiled for 10 min 
at 95°C and spun down at 10,000 × g for 5 min. supernatant was used directly as a DNA template for 
PCR). 
 
2.5 PCR Primers  
Primers in (Table, 1) were provided by CinnaGen and designed based on the complete annotation 
sequence of Escherichia coli 16SrRNA and Gentamicin resistant (aacC2) gene exhibited by the 
National Centre for Biotechnology Information (Accession No. J01859.1, Accession No.X51534.1). 
Bacteria Primers Primer sequence(5′-3′) Product 
size(bp) 
Reference 




627 This study 
Escherichia coli 16SrRNA-F 
16SrRNA-R 
GAA GAA GCT TGC TTC TTT GCT 
G 
GAG CCC GGG GAT TTC ACA T 
544 ( Sabat et 





CGG AAG GCA ATA ACG GAG 
GCA AT 









TAG AGG AGA TAT CGC GAT GC 
ATT ATC ATT GTC GAC GGC CT 
896 (Ho et al., 
2010)  
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          Table 1: Sequence, symbol, and product size of designed and reference primers  
2.6 PCR Amplification (16S rRNA and aacC2 gene)  
PCR assay performed in 25µl final reaction volume, consisted of 2µl of DNA template, 0.5µl for 
each primer, 12.5µl of One PCR
TM
 master mix (GeneDirex), consisted of Taq DNA polymerase, 
PCR buffer, dNTPs, gel loading dye, enhancer, and fluorescence dye. The volume of the reaction 
was completed with the addition of nuclease free water. The PCR mixtures were spun down shortly 
for 5-10 seconds, then placed in thermal cycler (TCY, Crealcon, NL) and subjected to the following 
cycling conditions: initial denaturation at 94°C for 4minutes, followed by 35 cycle of denaturation at 
94°C for 30 seconds, annealing at 55°C for 1minute and extension at 72°C for 2minutes and a final 
extension step at 72
°C
 for 5minutes. 
 
Amplified DNA fragments were visualized in 1.5% agarose gel electrophoresis containing ethidium 
bromide at 90 volts for 60 minutes at room temperature. Amplicon size determined by comparison 
with 100 bp DNA ladder (GeneDirex). 
 
2.7 Statistical analysis 
 
Data were analysed using Statistical Package for Social Sciences (SPSS, 2009). Probability values of 
P< 0.05 were considered as statistically significant. 
 
3. Results and Discussion 
3.1 Incidence of Bacteriuria 
 
During the embarked study, 142 MSU samples gathered from recruited pregnant women with 
symptomatic and asymptomatic bacteriuria. Our data (Table, 2) declared 31 (21.8%) samples 
positive for Enterobacteriaceae, 19(25.7%) of them accounted as ASB, while 13 (17.6%) were SB. 
Previous finding overwhelmingly was not statistically significant (P value > 0.05). Results of (Rizvi 
et al., 2011) are underpinning our findings via showing higher incidence of ASB (74.8%) than SB 
(25.2%). This might be due to silent infection that has been left without being investigated at early 
stages, the fact that supports the concurrent recommendation of routine screening for UTI in 
pregnant women during the first visit to the hospital to avoid unwanted complications (McIsaac et 
al., 2005). However, it contradicts an earlier report by (Masinde et al., 2009) who displayed the 
incidence of SB and ASB as 17.9% and 13.0%, respectively. 
 
Concerning age groups, individuals of the age group 25-29 years had the highest incidence of 
infection (29.2%). The second highest age group was 40-44 years (28.6%), and lesser rates were with 
the remaining age groups (Table, 2), which is statistically insignificant. Our observation tends to 
agree with that of Akobi et al., (2014). On the other hand, it is in contrast with the findings of 
Kawser et al., (2011) in which the age group 21-25 years occupied the first foremost of the age 
bracket 16 to 40 years. This discrepancy could be due to multiparity as well as more sexual activity 
as two possible factors influencing the fluctuation of UTI among pregnant women. Interestingly, 
significant outcomes were observed when samples distributed over gestational periods. Pregnant 
women in third trimester had the highest incidence (32.81%), accompanied by second trimester 
(14.81%). This is consistent with previous report by Okonko et al., (2009). Surprisingly, Turay et al., 
(2014) revealed the first and second trimesters as having the greatest rate of infection, which 
counteract current observation. Races, geographical distribution, poverty, and different locations 
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where studies had been executed might explain the differences.  
 
It is predicted that the endangerment of UTI possibly commence within week six, and reach 
maximum peak within 22-24
th
 week of pregnancy (Rahimkhani et al., 2006). Furthermore, as a 
consequence of increased in uterus weight and development, passage of urine from the bladder can 
be obstructed leading to infection. In addition, dilatation of the uterus caused by muscular flexibility 
as a result of a raise in progesterone level, in turn minimize the flow of urine (Fasalu et al., 2015).  
 





























3.2 Gram Negative Bacterial Profile 
 
Within 31 isolates of Enterobacteriaceae identified by biochemical tests, suspicious one confirmed 
using BIOMÉRIEUX VITEK 2 system. 13(41.9%) E. coli strains ranked as the dominant organism. 
K. pneumoniae 6(19.4%) ranked next. 4(12.9%) of the isolates were P. aeruginosa and 2(6.5%) were 
P. vulgaris, respectively. The rest (Table, 3) were found equally. Of a special concern, strains of E. 
coli were molecularly identified by PCR (Figure, 1). This observation seems to agree to high extent 
with the findings of numerous other researchers. For example, Okonko et al., (2009) and Manjula et 
al., (2013) independently reported E. coli, Klebsiella sp. and P. aeruginosa as the 3 most common 
organisms implicated in UTIs, while results exhibited by Battikhi and Battikhi, (2015) revealed E. 
coli, and K. pneumonia with the highest incidence rate. In contrary, Ezeigbo et al., (2016) announced 
that P. mirabilis occupied next to E. coli as the most predominant organisms. Stamey and Sexton, 













Symptoms of UTI 
SB 12(17.6) 56(82.3) 68(47.9) 
1.339 .247 ASB 19(25.7) 55(74.3) 74(52.1) 
Total 31(21.8) 111(78.2) 142(100) 
Age (Years) 
   15-19 Years 2(25) 6(75) 8(5.6) 
4.222 .518 
   20-24 Years 6(15.4) 33(84.6) 39(27.5) 
   25-29 Years 14(29.2) 34(70.8) 48(33.8) 
   30-34 Years 6(22.2) 21(77.8) 27(19) 
   35-39 Years 1(7.7) 12(92.3) 13(9.2) 
   40-44 Years 2(28.6) 5(71.4) 7(4.9) 








8(14.81) 46(85.19) 54(38) 
Third 
Trimester 
21(32.81) 43(67.19) 64(45.1) 
Total 31(21.8) 111(78.2) 142(100) 
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faecal-urethral path. Additional factor that encourage microbial growth and predisposes females to 
bladder contamination, in particular during pregnancy, is the female’s perineum with moist 
environment (Ebie et al., 2001). Moreover, pregnant women suffers from difficulties to clean the 
perineum properly contribute to increase in the incidence of UTIs (Demilie et al., 2012). Since 
implication of E. coli in UTI is becoming a fact, it could be due to various factors that had been 
proposed by investigators at different times and locations. pH and osmotic pressure of the females 
urine was found as two factors promotes the growth of E. coli (Asscher, 1981; Obiogbolu et al., 
2009). It is predicted that a significant increase in the level of lactose and amino acids during the 
gestational period enhance the growth of E. coli in urine (Weatheral et al., 1988). 























Figure 1: Molecular identification of UPEC isolates. M: 100bp DNA marker. +ve; positive control 
(E. coli ATCC 25922), -ve; negative control. Lanes 1 to 12; PCR amplification of 16SrRNA of E. 
coli isolates. 
 
3.3 Antimicrobial Susceptibility Pattern  
 
Results (Table, 4) illustrate the response of 31 isolates to 13 different antimicrobial agents. 
Microorganisms of the current study were highly resistance to AMC and PG with a rate of (100%), 
while expressed less resistant (96.8%) to AX, CL, and VA. Moreover, progressive resistance to RA 
(74.2%), F (71%), and NA (61.3%) has been achieved. These results are worrisome since it might 
means excessive and unnecessary use of antibiotics, which most of them tend to be safe for treating 
patients with UTIs, especially pregnant women. Therefore, in order to minimize resistant 
dissemination, non- 
No.  ASB SB No(%) 
1 Escherichia coli 4 9 13(41.9) 





4 Proteus vulgaris 2 0 2(6.5) 
5 Citrobacter koseri 1 0 1(3.2) 
6 Serratia marcescens 1 0 1(3.2) 
7 Enterobacter spp.  1 0 1(3.2) 
8 Morganella morganii 1 0 1(3.2) 
9 Proteus mirabilis  1 0 1(3.2) 
10 Salmonella typhimurium 1 0 1(3.2) 
  19 12  
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essential use and prescription of antibiotics should be avoided. Since this study carried out in a 
developing country, the case looks quite similar to that in Vietnam and Uganda, as the antibiotics can 
be obtained via private providers without been prescribed by professionals from health sector. 
However, the case is clearly different in developed countries such as in Sweden. Thus, low level of 
resistance among bacterial isolates may be a consequence of both less use of antibiotics and carefully 
monitored by clinical health practitioners (Ramos et al., 2012). Fortunately, Amikacin scored the 
highest rate of antibacterial activity (90.3%) spreading over all the isolates, in particular against E. 
coli (92.3%). This achievement is appropriate with the data presented by Rizvi et al., (2011) when 
they showed that AK had a strongest antimicrobial activity. More specifically, Soleimani et al., 
(2016) revealed that the rate of resistance to aminoglycosides is approximately high, in spite of that; 
amikacin appeared to be the most effective one towards the UPEC. 
 
It is of essential to point out that only strains of UPEC subjected to three extra antibiotics from 
various groups (Figure, 2). Those were Streptomycin, Ciprofloxacin, and Ceftriaxone. Rate of 
resistance of UPEC to them were 7.3%, 15.4%, and 23%, respectively. Our data is in agreement with 
earlier reports, for example, May, (2011) revealed that 9.1% of the isolates were resistance to 
streptomycin, and Masinde et al., (2009) showed that 11.8%, and 29.4% of their isolates were 
resistance to ciprofloxacin, and ceftriaxone. Although, these findings demonstrate that we have 
multi-drug resistance (MDR) E. coli, it also explains the effectiveness of the mentioned antibiotics 
towards the target bacteria. However, we should not neglect their side effects, especially to pregnant 
women, such as the foetal arthopathy of ciprofloxacin (Masinde et al., 2009). Resistance rate of 
UPEC isolates of Akobi et al., (2014) contradict ours, who showed that 70.9%, and 64.9% of them 
were resistance to streptomycin, and ceftriaxone, respectively.  E. coli isolates from surgical wound 
infections exhibited different antimicrobial susceptibilities. Their resistance against streptomycin, 
Ciprofloxacin, and ceftriaxone were (72.4%), (75.9%), and (82.8%), respectively (Muhammad et al., 
2009). On the contrary, all the 57 E. coli strains from slaughtered commercial chickens were 
susceptible to streptomycin (Momtaz et al., 2012). Therefore, these discrepancies in the behaviour of 
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antimicrobial susceptibility of E. coli strains could only be interpreted on the basis of the proper 














Figure 2: Susceptibility of E. coli isolates to antibiotics from various groups. S; sensitive, R; 
resistance 
  
 3.4 Molecular Detection of aacC(2) by PCR       
One of the most important purposes of this study was to analyse antibacterial resistance of UPEC 
isolates phenotypically, and at molecular level, especially to investigate the occurrence of genes 
conferring resistance to aminoglycosides, specifically to gentamicin. Plate bioassay showed 
4(30.8%) of UPEC isolates resistance to CN. This achievement tend to be in close conformity with 
AST profiles since 3(23.1%) of the described isolates were positive for the aacC(2) gene (Figure, 3). 
It also means that 75% of them harbouring the gene of concern. Earlier reports by Dias-Goncalves et 
al., (2015) exhibited that 80% of the gentamicin-resistant E. coli possessed the aacC(2)gene. Further 
report by Ho et al., (2010) monitor the presence of aacC(2)gene in isolates from human (84.1%) and 
animal (75.5%), respectively.  The high dissemination of the studied gene in genetically diverse 
strains signifies to high extent the substantial role of horizontal gene transfer in the increase of the 
level of gentamicin-resistance. Worthwhile, the sole isolate, which account for (25%) of CN resistant 
strains that we were unable to demonstrate the aacC(2) gene in, might be due to one of the 
possibilities other than aminoglycoside enzymatic modifications; including reduced uptake and 
increased efflux pump, and conversion of the target RNA (Houghton et al., 2010). The incidence of a 
new aminoglycoside acetyltransferase gene suggested by Cabrera et al., (2009) is another prospect. 
 
 
Figure 3: PCR identification of aacC(2) gene in UPEC strains resistant to gentamicin by disc 
diffusion assay.M: 100bp DNA marker. Lanes 1 to 3; PCR amplification of aacC(2) gene 
4. Conclusion & Recommendations  
It can be concluded from the current study that, incidence of ASB was 25.7%. E. coli were revealed 
as the most common organism among all the isolates of Enterobacteriaceae regardless of the cases 
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studied, whether SB or ASB. Majority of E. coli strains were sensitive to amikacin, streptomycin, 
ciprofloxacin, azithromycin, ceftriaxone and tetracycline. It is worth mentioning that a huge number 
of the strains were resistant to penicillin G, amoxicillin, amoxicillin-clavulanic acid, cephalexin, 
vancomycin. This indicates that multidrug resistance E. coli evolved at risky level. Molecular 
approach conducted to ascertain the presence of aacC(2) gene. The current situation is mostly 
contributed to both the non-controlled and non-licensed use of antibiotics. So it imposed the duty on 
the government to put optimum censoring on antibiotics administration, especially in developing 
countries and more specifically for pregnant women. 
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